Aperio Receives ScanScope® Patent
 Virtual Microscopy leader Aperio Technologies receives Patent for Ultra-fast Slide Scanning Technology

(Back to Press Releases Page)

Vista, CA – March 23, 2004 – Aperio Technologies, Inc. announces that the United States Patent and Trademark office issued US Patent No. 6,711,283 entitled “Fully Automatic Rapid Microscope Slide Scanner” to Aperio Technologies.

Patent 6,711,283 discloses Aperio’s novel line-scanning approach for rapidly digitizing entire microscope slides.  Allowed claims encompass the use of a linear-array detector, in microscopy, for purposes of creating a virtual microscope slide.

Virtual microscopy is the digital equivalent of traditional microscopy. Instead of looking through the eyepieces of a microscope, a digital image (virtual slide) of an entire slide is viewed on a display monitor. Virtual slide can be viewed, panned and zoomed on a computer monitor, from anywhere in the world, with the same efficiency as a glass slide under a microscope.  Virtual microscopy holds immense potential in pathology and related applications, where virtual slides can be analyzed by computer software (algorithms) to increase efficiency and improve diagnostic accuracy.  

“This patent highlights the fundamental differences between the ScanScope® (line-scanning) technology and the (image-tiling) approaches of others” said Dirk Soenksen, Aperio’s CEO.  “We look forward to the timely issuance of related patents to protect all other aspects of our technology.”

The patent document may be viewed here (PDF).


About Aperio Technologies, Inc.

Aperio Technologies (www.aperio.com), based in Vista, CA, develops software and instrumentation for virtual microscopy.  Aperio develops tools for viewing, annotating, storing and analyzing scanned microscope slides.  The Company is dedicated to establishing the ScanScope as the industry-standard slide-scanning platform.  Aperio’s offers a slide scanning service and virtual slide gallery at www.scanscope.com.
* Aperio products are FDA cleared for specific clinical applications, and are intended for research use for other applications.